JENNIFER BENSON: Open Payments
NPI 1548548084 · SAINT JOSEPH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 42 payments from 13 companies in 2025. Trend: 2023 $1,190 · 2024 $1,332 · 2025 $931
Food & beverage: $931
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $216 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $175 |
| Regeneron Healthcare Solutions, Inc. | 3 | $142 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $92 |
| Lilly USA, LLC | 3 | $67 |
| PFIZER INC. | 3 | $52 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
| Ipsen Biopharmaceuticals, Inc | 2 | $38 |
| Novo Nordisk Inc | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $23 |
Products named: DUPIXENT, RINVOQ, XIFAXAN, ENTYVIO, OMVOH, GATTEX, XELJANZ, ZENPEP.
Industry payments across MI — which companies pay providers there.
